360.50p+0.00 (+0.00%)14 May 2021, 18:29
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Puretech Health PLC Fundamentals

Company NamePuretech Health PLCLast Updated2021-05-14
Shares in Issue285.899 mMarket Cap£1.03 bn
PE Ratio256.41Dividend per Share0
Dividend Yield0Dividend Cover0
EPS$0.02EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0774Debt Equity Ratio0.0700
Asset Equity Ratio1.5148Cash Equity Ratio0.6180
Quick Ratio2.2465Current Ratio2.29
Price To Book Value2.1636ROCE0

Puretech Health PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Puretech Health PLC Company Financials

Tangible Assets$42.87 m$43.84 m$8.32 m
Intangible Assets$899,000.00$625,000.00$3.08 m
Investments$530.16 m$725.55 m$169.75 m
Total Fixed Assets$575.64 m$772.33 m$181.98 m
Debtors$2.56 m$1.98 m$1.33 m
Cash & Equivalents$403.88 m$162.45 m$250.88 m
Other Assets000
Total Assets$989.99 m$941.18 m$441.76 m
Creditors within 1 year$180.92 m$139.20 m$265.76 m
Creditors after 1 year$155.53 m$151.58 m$9.03 m
Other Liabilities000
Total Liabilities$336.45 m$290.78 m$274.79 m
Net assets$653.54 m$650.40 m$166.97 m
Called up share capital$5.42 m$5.41 m$5.38 m
Share Premium$288.98 m$287.96 m$278.38 m
Profit / Loss$18.97 m$478.47 m-$68.44 m
Other Equity$669.75 m$668.04 m$275.51 m
Preference & Minorities-$16.21 m-$17.64 m-$108.53 m
Total Capital Employed$653.54 m$650.40 m$166.97 m
Debt Ratio$0.07$0.05$0.00
Assets / Equity1.51481.51481.5148
Cash / Equity0.61800.61800.6180
Cash Flow202020192018
Cash from operating activities-$131.83 m-$98.16 m-$72.80 m
Cashflow before financing-$92.96 m-$48.25 m$84.09 m
Increase in Cash$271.52 m$15.31 m$44.40 m
Turnover$11.77 m$9.81 m$20.75 m
Cost of sales000
Gross Profit000
Operating Profit-$119.53 m-$135.40 m-$104.02 m
Pre-Tax profit$18.97 m$478.47 m-$68.44 m

Puretech Health PLC Company Background

ActivitiesPureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on areas of growing scientific and technical insights that it believes are at an important inflection point, including the central nervous, gastrointestinal and immune systems, and the interactions and signaling between them. The company has a robust pipeline of advanced programs that are post-human proof of concept, focused on addressing some of the society's healthcare needs.
Latest Interim Date27 Aug 2020
Latest Fiscal Year End Date15 Apr 2021

Puretech Health PLC Directors

2020-08-27Dr. Bennett M. ShapiroNon-Executive Director
2020-11-02Dr. John L. Lamattina, PhDNon-Executive Director
2020-12-21Dr. Robert S. Langer, Sc.D.Non-Executive Director
2020-04-21Dr. Raju S. Kucherlapati, PhDNon-Executive Director
2019-09-09Mr. Joichi ItoNon-Executive Director,Chairman
2020-11-27Ms. Marjorie Morris ScardinoNon-Executive Director
2020-11-19Mr. Christopher ViehbacherNon-Executive Director,Chairman (Interim)
2020-11-13Ms. Daphna ZoharExecutive Director,Chief Executive Officer
2020-06-22Mr. Stephen Muniz, J.D.Executive Director,Chief Operating Officer and Company Secretary

Puretech Health PLC Contact Details

Company NamePureTech Health PLC
Address6 St Andrew Street, 5th Floor, London, EC4A 3AE

Puretech Health PLC Advisors

StockbrokerPeel Hunt LLP
Phone+44 2074188900
StockbrokerJefferies Hoare Govett
Phone+44 2070298000
Fax+44 2070298010
StockbrokerNumis Securities Limited
Phone+44 2072601000
Remuneration ConsultantNew Bridge Street
Phone+44 2070869341
Fax+44 2070869341
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
Phone+44 2073111000
Fax+44 2073113311
SolicitorDLA Piper LLP
Phone+44 8700111111
Fax+44 2077966666
RegistrarComputershare Investor Services PLC
Phone+44 3707020003
Fax+44 3707036101